<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B73BEA54-A154-4D2E-A8F8-F748BA43965E"><gtr:id>B73BEA54-A154-4D2E-A8F8-F748BA43965E</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Simon</gtr:otherNames><gtr:surname>Arthur</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12016%2F10"><gtr:id>CE8EB10C-E982-4F08-8E69-BF6378BDB691</gtr:id><gtr:title>The functions of MAPK signalling pathways in cell regulation and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12016/10</gtr:grantReference><gtr:abstractText>In order for an animal to survive, its individual cells must be able to communicate with each other and respond appropriately to external factors such as changes in their environment or infection. The main way in which a cell achieves this is through the activation of intracellular signalling networks. These have many roles, but one important aspect of their function is regulating which genes are active in the cell, since changes in gene regulation are important in mediating many of the long-term effects of signalling. Deregulation of signalling networks and gene regulation frequently has adverse effects and occurs in many diseases, including cancer, neurodegeneration and inflammatory diseases such as arthritis and asthma. Compounds that selectively target these mechanisms therefore have great potential to treat these diseases. Indeed some have already been approved for use or are in clinical trials. Despite advances in this area, much is still not understood about the regulation of normal and pathological function, of the various signalling cascades in cells. Our work is focused on the functions of mitogen activated protein kinase signalling cascades, one of the signalling cascades implicated in cancer and inflammatory disease. In particular we are interested in understanding how they regulate the transcription of specific genes and how this in turn affects the function of cells in neuronal and immune systems.</gtr:abstractText><gtr:technicalSummary>Mitogen activated protein kinase (MAPK) cascades are important mediators of a cells response to external signals such as mitogens and cellular stress, and are implicated in many cellular process including cell survival, proliferation, differentiation and migration. Deregulation of MAPKs is implicated in several diseases including inflammation, cancer, neurodegeneration and addiction, and drugs that target these kinases may represent a powerful way of treating these diseases. Despite this, the downstream mechanisms by which MAPKs produce the appropriate responses in cells are not well understood. We are interested in how activation of the MAPKs p38 MAPK and the MAPK-activated kinases MSK1 and MSK2, controls physiological or pathological functions in cells. While MAPK signalling is important for the correct function of many cell types and tissues, several of these kinases, including MSK1 and 2 are highly expressed in immune and neuronal cells. One reason for this may be that both cell types respond rapidly and continuously to extra-cellular signals. We are investigating the roles that MSK and p38 MAPKs play in neuronal and immune model systems using a combination of gene targeted mice, specific cell permeable inhibitors, microarrays, QPCR and proteomic techniques. We are especially interested in how MAPK signalling controls transcriptional reprogramming in neurons and immune cells, both by targeting specific transcription factors, such as CREB and ATF1, and by modifying chromatin proteins such as histone H3. We are also interested in the roles that MAPKs play in the negative regulation in the innate immune system. Finally we are also interested in the intriguing possibility that MAPK signalling may regulate the production of specific microRNAs in cells. In collaboration with others we are also looking at the effect of the gene targeting of MAPKs in models of arthritis and inflammatory bowel disease, inflammatory pain, addiction and circadian rhythms. Together, these studies should increase our understanding the physiological and pathological roles MAPK signalling in the CNS and immune systems, and identify potential targets for therapeutic intervention in these systems.</gtr:technicalSummary><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>455000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB5A70E2-766C-45A7-A6CB-A38E3C0C9A78</gtr:id><gtr:title>Transcriptional regulation of IL-10 and its cell-specific role in vivo.</gtr:title><gtr:parentPublicationTitle>Critical reviews in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96b40aa5de27031cfad4d0acc4814787"><gtr:id>96b40aa5de27031cfad4d0acc4814787</gtr:id><gtr:otherNames>MacKenzie KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1040-8401</gtr:issn><gtr:outcomeId>545aa835a27281.06061019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3856F1C9-8017-48F0-B6B6-7A4EB6BB791E</gtr:id><gtr:title>The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf1ecd4c4c7b837a4d6237fe9fed466"><gtr:id>2bf1ecd4c4c7b837a4d6237fe9fed466</gtr:id><gtr:otherNames>Zhou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>56d17fce3c1507.54188897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8092C94E-1A82-4E3F-9863-632F7742D8C4</gtr:id><gtr:title>X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0ab398656dd7877220c9c0d98b10b65"><gtr:id>e0ab398656dd7877220c9c0d98b10b65</gtr:id><gtr:otherNames>Elkins JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>pm_13967_27_23656407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BC12A8F-46E6-405C-9637-24E5A846A07C</gtr:id><gtr:title>Mitogen and stress-activated kinases 1/2 regulate ischemia-induced hippocampal progenitor cell proliferation and neurogenesis.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619ce0d26de1bfa57c546ec57ae2acaa"><gtr:id>619ce0d26de1bfa57c546ec57ae2acaa</gtr:id><gtr:otherNames>Karelina K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>56d17fce94cdd0.09159440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4589703C-3E5C-4613-8661-D73A0E34DEDE</gtr:id><gtr:title>CREB phosphorylation at Ser133 regulates transcription via distinct mechanisms downstream of cAMP and MAPK signalling.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01c69a027bae739bd5e502b251904cde"><gtr:id>01c69a027bae739bd5e502b251904cde</gtr:id><gtr:otherNames>Naqvi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>545aa835f00901.85716926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF959B05-8055-48A0-BF12-14AE03E00DE4</gtr:id><gtr:title>RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aee1ee63386515068fab667d68cc059"><gtr:id>9aee1ee63386515068fab667d68cc059</gtr:id><gtr:otherNames>Park J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_13967_27_23719381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EDDCDD6-6C23-43F4-919C-BCD68881DED6</gtr:id><gtr:title>Beta Interferon Production Is Regulated by p38 Mitogen-Activated Protein Kinase in Macrophages via both MSK1/2- and Tristetraprolin-Dependent Pathways.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a421ad3f54cb2085f40ce1aa163aada7"><gtr:id>a421ad3f54cb2085f40ce1aa163aada7</gtr:id><gtr:otherNames>McGuire VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>58321897618172.61368108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D08E59E-AEB8-447C-BCF4-408D3C5E917C</gtr:id><gtr:title>Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a421ad3f54cb2085f40ce1aa163aada7"><gtr:id>a421ad3f54cb2085f40ce1aa163aada7</gtr:id><gtr:otherNames>McGuire VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58321897347c11.86415377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C59C3CCB-641C-45E2-ACD0-AF443FB3F8E0</gtr:id><gtr:title>PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53aa6c345bb21e935cec0b6ad51b8b7"><gtr:id>a53aa6c345bb21e935cec0b6ad51b8b7</gtr:id><gtr:otherNames>Venigalla RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_13967_27_23463102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C684F026-028A-4BE8-968D-812D85C08F3C</gtr:id><gtr:title>IFN? autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/666acae4fc9bd018ea6fd6dcde06d8c6"><gtr:id>666acae4fc9bd018ea6fd6dcde06d8c6</gtr:id><gtr:otherNames>Pattison MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_13967_27_23542035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>116CC2C6-4933-42EC-9587-CE2E4C84F700</gtr:id><gtr:title>Mitogen-activated protein kinases in innate immunity.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a21be5f3537f96d3a0ca85d061dd2a06"><gtr:id>a21be5f3537f96d3a0ca85d061dd2a06</gtr:id><gtr:otherNames>Arthur JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_13967_27_23954936</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12016/10</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>